A detailed history of Planning Capital Management Corp transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Planning Capital Management Corp holds 691 shares of DVAX stock, worth $9,003. This represents 0.01% of its overall portfolio holdings.

Number of Shares
691
Previous 691 -0.0%
Holding current value
$9,003
Previous $7.76 Million 0.8%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$10.73 - $12.58 $1,802 - $2,113
168 Added 32.12%
691 $7.76 Million
Q1 2024

Apr 26, 2024

BUY
$11.7 - $14.98 $6,119 - $7,834
523 New
523 $6.49 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.65B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Planning Capital Management Corp Portfolio

Follow Planning Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Planning Capital Management Corp with notifications on news.